CorMedix Therapeutics
Gold Member
Can you share a brief summary of what your company does and how that fits into the home & alternate site infusion industry?
CorMedix Therapeutics is a biopharmaceutical company that develops and delivers breakthrough therapies for the prevention and treatment of life-threatening illnesses, ensuring patients have access to our innovative products while building an organization that values integrity, collaboration, and performance. Through collaboration with healthcare providers, we ensure that the patients who need our therapies receive them.
What are you most looking forward to at the NHIA Annual Conference?
We look forward to connecting with our industry colleagues and customers at NHIA 2026.
What are the biggest challenges your customers are currently facing?
Medicare’s payment structure for home-based care continues to be a hurdle for patients’ access to these services. NHIA’s proposed legislation with the Preserving Patient Access to Home Infusion Act would provide a solution to this challenge.
What are you most excited to share with attendees at the conference?
We are excited to share how our innovative products can support conference attendees and the patients they care for
What are you most excited to share with attendees at the conference?
We are excited to discuss our portfolio of anti-infective medications and how they can help appropriate patients get the treatments they need.
